| Followers | 70 |
| Posts | 1840 |
| Boards Moderated | 0 |
| Alias Born | 03/10/2017 |
Friday, April 21, 2023 11:49:27 AM
Explain? Obviously any price prediction is futile but if that was a P&D, it was the worst spend 600k in history. Company has some very tangible catalyst. But I think the rush to increase share price is surrounding the buyout/merge gossip. You don't see the unusual off peak share activity in a failed P&D.
Recent BTCY News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/12/2026 08:05:38 PM
- Biotricity, Inc to Present at the LD Micro Invitational XVI • Newsfile • 05/12/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 09:28:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 10:30:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 09:29:05 PM
- Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA • GlobeNewswire Inc. • 02/11/2026 09:00:00 PM
- Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th • GlobeNewswire Inc. • 02/05/2026 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2025 09:05:51 PM
- Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026 • GlobeNewswire Inc. • 11/14/2025 09:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 08:38:49 PM
- Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th • GlobeNewswire Inc. • 11/07/2025 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 11:01:14 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/15/2025 09:27:01 PM
